The development of new drugs requires continous research. Safe and effective medicine is of eminent value for society.
Clinical Pharmacology Unit, First Department of Medicine, University of Debrecen and Pharma Research Services Ltd. are affiliated university and independent scientific institutes performing small-scale, well-controlled clinical pharmacology studies.
   Our aim is to set the golden quality standard for clinical pharmacology by delivering the highest achievable quality with performing all studies in full compliance with international requirements.

   PHARMA RESEARCH SERVICES LTD. is a modern Hungarian based CRO organization affiliated with the Clinical Pharmacology Unit, First Department of Medicine, University Debrecen (Hungary) . Founded in 1993 it carried out clinical pharmacology studies as a CRO and jointly with CPU. It specializes in Phase I. and bioequivalence studies and covers the whole range of clinical research in all fields of medical science.

   CLINICAL PHARMACOLOGY UNIT, First Department of Medicine, University Debrecen (Hungary) was founded in 1974 and was part of an official national clinical pharmacology service based on university institutes. Since 1988 it performed also Phase I. studies, it carried out clinical pharmacology studies as the clinical investigation site of the Clinical Pharmacology Research enter of the University Medical Scholl. It carried out studies in close cooperation with the PRS Ltd. for hungarian and foreign pharmaceutical companies.

   Members of PRS and CPU the experience of working under EC and FDA GCP regulations in the preparation of Protocols and Case Report Forms, execution of studies compilation of Reports (according to ICH Guidelines) and statistical evaluation by own Biometrical Unit.

   In all its undertakings PRS and CPU aims to provide its clients with personalised, responsive service, thorough investigation, reporting and maintenance of absolute confidentiality.
 





   In Hungary 4 sites (institutes) are approved and licensed for Phase I. and bioequivalence studies by the national authority (National Institute of Pharmacy). One site in Budapest is licensed for oncology studies. There are two institutes approved for Phase I. and bioequivalence studies in Budapest and our CPU of the First Department of Medicine, University Debrecen (Hungary) is the only approved and licensed orgaisation for such studies in the whole eastern part of Hungary.